Psychiatry Clin Neurosci. 2014 Apr;68(4):245-54. doi: 10.1111/pcn.12118.
The aim of this study was to compare the symptomatic and clinical features of depression among five groups of patients with major depressive disorder (MDD) living in China, Korea, Malaysia/Singapore, Taiwan, and Thailand.
Consecutive consenting adults (aged 18-65) who met DSM-IV criteria for non-psychotic MDD – based on the Mini International Neuropsychiatric Interview – and who were free of psychotropic medication were evaluated in a cross-sectional study. Depressive symptoms were evaluated using the 10-item Montgomery–Asberg Depression Rating Scale (MADRS) and the 13-item depression subscale of the Symptoms Checklist 90-Revised (SCL-90-R). In addition, the 10-item SCL-90-R Anxiety Subscale was completed. ancova were conducted, adjusting for confounders: age, completion of secondary education, marital status, work status, religion, index episode duration, and depressive severity. For the magnitude of differences, a threshold of 0.10 was taken as the minimum effect size representing clinical significance, and an effect size of 0.25 was considered moderate.
Four MADRS symptoms differentiated these five groups, the most prominent being ‘lassitude’ and ‘inner tension’. Nine SCL-90-R depression items also differentiated the groups, as did eight SCL-90-R Anxiety Subscale items. The MADRS lassitude item had the largest effect size (0.131). The rest of those statistically significant differences did not exceed 0.10.
MDD is more similar than different among outpatients in these diverse Asian countries. The between-country differences, while present and not due to chance, are small enough to enable the use of common clinician and self-report rating scales in studies involving Asians with MDD from various ethnic backgrounds.
本研究旨在比较生活在中国、韩国、马来西亚/新加坡、中国台湾和泰国的五组重性抑郁障碍(MDD)患者的抑郁症状和临床特征。
采用横断面研究,连续纳入符合 DSM-IV 非精神病性 MDD 诊断标准(基于 Mini 国际神经精神访谈)且未服用精神药物的成年患者。使用 10 项蒙哥马利-阿斯伯格抑郁评定量表(MADRS)和症状清单 90 修订版(SCL-90-R)的 13 项抑郁子量表评估抑郁症状。此外,还完成了 SCL-90-R 焦虑子量表的 10 项条目。采用协方差分析(ANCOVA),调整混杂因素:年龄、完成中学教育、婚姻状况、工作状况、宗教、首发病程和抑郁严重程度。对于差异程度,以 0.10 作为代表临床意义的最小效应量阈值,以 0.25 作为中度效应量阈值。
四项 MADRS 症状可区分这五组,其中最突出的是“懒散”和“内心紧张”。九项 SCL-90-R 抑郁条目和八项 SCL-90-R 焦虑子量表条目也可区分这些组。MADRS 懒散条目具有最大的效应量(0.131)。其余具有统计学意义的差异均未超过 0.10。
在这些不同的亚洲国家中,门诊患者的 MDD 更相似而非不同。虽然存在且并非偶然的国家间差异很小,但足以使来自不同种族背景的亚洲 MDD 患者的研究能够使用共同的临床医生和自我报告的评定量表。